Submitted by Anonymous (not verified) on 17 December 2025 - 14:10
Opinion/decision on a Paediatric investigation plan (PIP): Stivarga, regorafenib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: EMA/PE/0000182170
Source: